In the acute MS lesions of CDMS, PPMS, and SPMS patients, increased PDE concentrations (mainly attributable to the glycerophosphocholine) have been found [145,146], confirming higher myelin phospholipid degradation. This evidence concerns the gene ALDH7A1 and myeloid sarcoma.